210 related articles for article (PubMed ID: 30588836)
1. The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?
Nobili V; Alisi A; Mosca A; Crudele A; Zaffina S; Denaro M; Smeriglio A; Trombetta D
Antioxid Redox Signal; 2019 Jul; 31(2):127-133. PubMed ID: 30588836
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
Mosca A; Crudele A; Smeriglio A; Braghini MR; Panera N; Comparcola D; Alterio A; Sartorelli MR; Tozzi G; Raponi M; Trombetta D; Alisi A
Dig Liver Dis; 2021 Sep; 53(9):1154-1158. PubMed ID: 33060043
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.
Zang S; Chen J; Song Y; Bai L; Chen J; Chi X; He F; Sheng H; Wang J; Xie S; Xie W; Yang Y; Zhang J; Zheng M; Zou Z; Wang B; Shi J;
Adv Ther; 2018 Feb; 35(2):218-231. PubMed ID: 29411270
[TBL] [Abstract][Full Text] [Related]
4. Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis.
Panera N; Braghini MR; Crudele A; Smeriglio A; Bianchi M; Condorelli AG; Nobili R; Conti LA; De Stefanis C; Lioci G; Gurrado F; Comparcola D; Mosca A; Sartorelli MR; Scoppola V; Svegliati-Baroni G; Trombetta D; Alisi A
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145170
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
El Amrousy D; Abdelhai D; Shawky D
Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
[TBL] [Abstract][Full Text] [Related]
6. Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease.
Alberti G; Gana JC; Santos JL
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33212947
[TBL] [Abstract][Full Text] [Related]
7. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
8. Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.
Polyzos SA; Kountouras J; Anastasilakis AD; Makras P; Hawa G; Sonnleitner L; Missbichler A; Doulberis M; Katsinelos P; Terpos E
Hormones (Athens); 2018 Dec; 17(4):573-579. PubMed ID: 30467685
[TBL] [Abstract][Full Text] [Related]
9. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
[TBL] [Abstract][Full Text] [Related]
10. Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Bril F; Biernacki DM; Kalavalapalli S; Lomonaco R; Subbarayan SK; Lai J; Tio F; Suman A; Orsak BK; Hecht J; Cusi K
Diabetes Care; 2019 Aug; 42(8):1481-1488. PubMed ID: 31332029
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
[TBL] [Abstract][Full Text] [Related]
12. Role of vitamin E in nonalcoholic fatty liver disease.
Nagashimada M; Ota T
IUBMB Life; 2019 Apr; 71(4):516-522. PubMed ID: 30592129
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of thymol and vitamin E on nonalcoholic fatty liver disease in male Wistar rats.
Lahmi A; Oryan S; Eidi A; Rohani AH
Braz J Biol; 2023; 84():e268781. PubMed ID: 36629640
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
Vadarlis A; Antza C; Bakaloudi DR; Doundoulakis I; Kalopitas G; Samara M; Dardavessis T; Maris T; Chourdakis M
J Gastroenterol Hepatol; 2021 Feb; 36(2):311-319. PubMed ID: 32810309
[TBL] [Abstract][Full Text] [Related]
15. Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
Della Corte C; Carpino G; De Vito R; De Stefanis C; Alisi A; Cianfarani S; Overi D; Mosca A; Stronati L; Cucchiara S; Raponi M; Gaudio E; Byrne CD; Nobili V
PLoS One; 2016; 11(12):e0168216. PubMed ID: 27977757
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.
Zöhrer E; Alisi A; Jahnel J; Mosca A; Della Corte C; Crudele A; Fauler G; Nobili V
Appl Physiol Nutr Metab; 2017 Sep; 42(9):948-954. PubMed ID: 28511023
[TBL] [Abstract][Full Text] [Related]
17. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
[TBL] [Abstract][Full Text] [Related]
18. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
19. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.
Sharifi N; Amani R; Hajiani E; Cheraghian B
Endocrine; 2014 Sep; 47(1):70-80. PubMed ID: 24968737
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
Federico A; Dallio M; Masarone M; Gravina AG; Di Sarno R; Tuccillo C; Cossiga V; Lama S; Stiuso P; Morisco F; Persico M; Loguercio C
Oxid Med Cell Longev; 2019; 2019():8742075. PubMed ID: 31737175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
